Monthly Archives - September 2017

Corbus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that Yuval Cohen, Ph.D., Chief Executive Officer, will present at the Cantor Fitzgerald Global Healthcare Conference on Monday, September 25, 2017 at 8:35 a.m. EDT in New York, NY. Read more >>

Hi-tech eSight glasses to help the legally blind see on the way to SA

STAR Trek-style smart glasses giving sight to the legally blind are coming to Adelaide, and today, Maureen Montes of Parkside becomes the first person in the nation to buy the $13,000 super specs.

Mrs Montes, who has less than 5 per cent vision and is legally blind, has trialled the Canadian eSight glasses and says the first time she wore them she was stunned. Read more >>

eSight 3 Launches in Australia and New Zealand

Dr. Brian Mech, President and CEO of eSight, is pleased to announce the launch of eSight 3 in Australia and New Zealand. eSight 3 sets the gold standard for the most sophisticated low vision glasses of their kind anywhere in the world, enabling the visually impaired to actually see, be mobile and independently carry out virtually all Activities of Daily Living (ADLs). Read more >>

Life-changing technology is helping blind people see

But the future is looking bright, or rather, clear, for Kasandra these days.
The 16-year-old sophomore is part of a growing client list for eSight, a set of electronic glasses that uses camera magnification to assist those for whom a prescription is not enough. It’s one of numerous tools geared toward the visually impaired to crop up on the market in recent years, and for Kasandra, who was fitted with her’s in February, it’s proved life-changing. Read more >>